Related Experiment Video
Updated: Aug 30, 2026

Spontaneous Murine Model of Anaplastic Thyroid Cancer
Published on: February 3, 2023
IFNgamma sensitization to TRAIL-induced apoptosis in human thyroid carcinoma cells by upregulating Bak expression
Su He Wang1, Emese Mezosi, Julie M Wolf
1Department of Medicine, University of Michigan Medical Center, Ann Arbor, MI, USA.
Abstract:
TRAIL preferentially induces apoptosis in tumor cells and virus-infected cells. Unlike other tumor necrosis factor family members, TRAIL does not kill cells from most normal tissues and has thus been proposed as a promising new cancer treatment. Our study demonstrated that IFNgamma combined with TRAIL can trigger apoptosis in vitro in several resistant thyroid tumor cell lines, such as thyroid anaplastic carcinoma cells (ARO cells), while either agent alone exerts only a minimal effect. We further tested this effect on a mouse thyroid tumor model, when in vivo tumor growth was also significantly inhibited by this combination. The mechanism of how IFNgamma sensitized thyroid carcinoma cells to TRAIL-induced apoptosis was investigated by screening global gene alterations in ARO cells treated with IFNgamma. Microarray data revealed that a proapoptotic gene, Bak, is markedly upregulated by IFNgamma, and this was confirmed by RNase protection assay. Western blot analysis also showed a significant increase in Bak at the protein level. Upregulation of Bak and sensitization for apoptosis by IFNgamma was blocked by overexpression of antisense Bak in ARO cells. Furthermore, overexpression of Bak sensitized ARO cell to TRAIL-induced apoptosis without the need for IFNgamma pretreatment. This suggests that Bak is a regulatory molecule involved in IFNgamma-facilitated TRAIL-mediated apoptosis in thyroid cancer cells.
Insights
Combining interferon-gamma (IFNγ) with TRAIL effectively triggers apoptosis in resistant thyroid cancer cells. This combination therapy significantly inhibits tumor growth in vivo, with Bak upregulation identified as a key mechanism.
Area of Science:
- Oncology
- Molecular Biology
- Immunology
Background:
- TRAIL (TNF-related apoptosis-inducing ligand) induces apoptosis in tumor cells and is a promising cancer treatment.
- TRAIL spares most normal tissues, distinguishing it from other TNF family members.
- Thyroid cancer, particularly anaplastic carcinoma, often exhibits resistance to conventional therapies.
Purpose of the Study:
- To investigate the synergistic effect of interferon-gamma (IFNγ) and TRAIL on resistant thyroid cancer cells.
- To elucidate the molecular mechanisms underlying IFNγ-sensitized TRAIL-induced apoptosis in thyroid cancer.
- To evaluate the in vitro and in vivo efficacy of the combined IFNγ and TRAIL therapy.
Main Methods:
- In vitro apoptosis assays on thyroid anaplastic carcinoma (ARO) cells treated with IFNγ and TRAIL.
- In vivo mouse thyroid tumor model to assess tumor growth inhibition.
- Microarray analysis to screen for gene alterations induced by IFNγ.
- RNase protection assay and Western blot to confirm Bak gene and protein expression.
- Gene silencing and overexpression studies using antisense Bak to validate its role.
Main Results:
- IFNγ combined with TRAIL induced significant apoptosis in resistant thyroid cancer cell lines (ARO cells), while single agents had minimal effect.
- The combination therapy significantly inhibited tumor growth in a mouse thyroid tumor model.
- Microarray analysis revealed marked upregulation of the proapoptotic gene Bak by IFNγ.
- Increased Bak expression at both mRNA and protein levels was confirmed, and this was essential for IFNγ-sensitized TRAIL-induced apoptosis.
- Overexpression of Bak alone sensitized ARO cells to TRAIL-induced apoptosis, bypassing the need for IFNγ.
Conclusions:
- IFNγ sensitizes resistant thyroid cancer cells to TRAIL-induced apoptosis.
- Bak is a critical mediator in the IFNγ-facilitated TRAIL-mediated apoptotic pathway in thyroid cancer.
- The combination of IFNγ and TRAIL, mediated by Bak upregulation, represents a potential therapeutic strategy for thyroid cancer.
Related Concept Videos
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
The Intrinsic Apoptotic Pathway
TGF - β Signaling Pathway
The Extrinsic Apoptotic Pathway
Enzyme-linked Receptors
Intracellular Signaling Affects Focal Adhesions
Some...
